The Valvular Interventions Center

Filter Your Results

 

News

 

An Interview With Josep Rodés-Cabau, MD

January/February 2017—Dr. Rodés-Cabau discusses the current landscape of transcatheter valve technologies, as well as his participation in innovative structural heart interventions.

Collaboration Allows TAVR to Reach its Potential

Christopher U. Meduri, MD, MPH; Meredith Brazell, PA-C; Bryan Griffith; Morris Brown, MD; Jim Kauten, MD; and Vivek Rajagopal, MD; on behalf of the Marcus Heart Valve Center, Piedmont Heart Institute, Atlanta, GA

November/December 2016—The advent of transcatheter aortic valve replacement (TAVR) has ushered in a new era of interdisciplinary collaboration in valve therapy and transformed the fields of both car…

TAVR Optimization Using Best Practices

Mathew Williams, MD; Michael Querijero, MSPA; and Tara Collins, MSPA; on behalf of New York University Langone Medical Center, New York, NY

November/December 2016—Transcatheter aortic valve replacement (TAVR) is a transformative therapy for patients with severe aortic stenosis. As the United States population ages, it can be expected th…

Building an Efficient TAVR Program

Sandeep M. Patel, MD; J. Brandon Elmore, MD; Edwin G. Avery, MD; Marco A. Costa, MD, PhD; Alan Markowitz, MD; Angela Davis, RN; and Guilherme F. Attizzani, MD; on behalf of The Valve Structural Heart Disease Intervention Center, Harrington Heart and Vascular Institute, Cleveland, OH

November/December 2016—Transcatheter aortic valve replacement (TAVR) represents one of the most important advances in the field of valvular heart disease management. From the first implantation in 2…

TAVR Economics in a Community Program

Hemal Gada, MD, MBA, and Mubashir Mumtaz, MD, FACS, FACC; on behalf of PinnacleHealth CardioVascular Institute, Harrisburg, PA

November/December 2016—PinnacleHealth CardioVascular Institute is the formal cardiac and cardiothoracic service line for PinnacleHealth System, a multicounty system of five hospitals surrounding Har…

Managing the Risk of Coronary Occlusion During TAVR

Carlos E. Sanchez, MD, FACC, FSCAI; Arash Arshi, MD, FACC, FSCAI; and Steven J. Yakubov, MD, FACC, FSCAI

September/October 2016—Effective planning for valve retrieval and coronary protection is essential.

Transcatheter Valve Implantation for Calcific Mitral Stenosis

Mayra Guerrero, MD; Dee Dee Wang, MD; Amit Pursnani, MD; Adam Greenbaum, MD; Michael Salinger, MD; Marvin Eng, MD; William O’Neill, MD; and Ted E. Feldman, MD

July/August 2016—TMVR with aortic THV devices might evolve into an acceptable alternative for selected patients with severe mitral annular calcification.

The Next Frontier of Percutaneous Tricuspid Valve Repair

Francesco Giannini, MD, and Azeem Latib, MD

July/August 2016—The development of percutaneous techniques as an alternative to surgical treatment.

 

advertisement

2017 Buyer’s Guide

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.